Living Networks, our mission.

Commitment

Living Networks, founded in 2024 by Jan Guzowski and Katarzyna Rojek, is transforming vascular tissue engineering and preclinical drug development with ultra-miniaturized human tissue models.

Using proprietary magnetic microcarrier technology, we enable scalable, automated, and reproducible assembly of vascular microtissues.

We re committed to push the boundaries of vascular research by combining automation, innovation, and data-driven insights to create the next-generation of human tissue models.

Solution

Preclinical tissue models in pharma are inefficient. 
The available in vitro human tissue models are either oversimplified, lacking vasculature, or exceedingly complex and poorly controlled, causing:

  1. Small levels of reproducibility

  2. Long turnover times

  3. Limited customization

  4. Lack of standards

Our platform co-assembles multiple microvasculatures in ordered arrays, boosting throughput, standardization, and efficiency of angiogenesis assays while preserving physiological relevance.

VTuA accelerates drug discovery, regenerative medicine, and disease modeling through precisely controlled vascular microenvironments.

Challenge

Team


Jan Guzowski, PhD

Katarzyna Rojek, PhD

Paweł Żuk, PhD

Leon Jurkiewicz

Partners


Institute of Physical Chemistry

Polish Academy of Sciences in Warsaw

Living Networks is a spin-off from IPC PAS, a leading research institution in Poland with interdisciplinary research portfolio at intersection of physics, chemistry and biology, and with a track record in successful commercialization (previous shareholder in a spin-off worth > $100 M). The Institute supports the company with access to research infrastructure including microfabrication and imaging facilities.

Industrial partnerships


metasThera

Academic collaborations